TYPE 1 INTO TYPE NONE Trademark
Serial Number: 99618178
Trademark Classes
Class 36 - Insurance & Financial
Insurance; financial affairs; monetary affairs; real estate affairs
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Class 35 - Advertising & Business
Advertising; business management; business administration; office functions
Owner Contact Info
Legal Representation
Correspondence Address
Emily R. Billig Baker, Donelson, Bearman, Caldwell & Berkowitz, A Professional Corporation
100 Light Street
Baltimore, MD 21202
United States
Trademark Details
Filing Date
January 27, 2026
Registration Date
Not Registered
Published for Opposition
June 23, 2026
Goods & Services
Providing information in the field of prevention, screening, diagnosis and treatment of type 1 diabetes; providing information in the field of prevention, screening, diagnosis and treatment of type 1 diabetes via a website; providing health information; providing health information in the field of type 1 diabetes
Charitable fundraising; on-line charitable fundraising; charitable fundraising services by means of organizing and conducting special events; charitable fundraising services by means of running and walking events; charitable fundraising services for promoting research and education relating to type 1 diabetes; charitable foundation services, namely, providing fundraising activities and investment management services to support type 1 diabetes research
Providing information about medical research; providing information about medical research in the field of type 1 diabetes; Providing information about medical and scientific research via a website; Providing medical and scientific research information in the field of clinical trials; Providing an online database in the field of medical and scientific research as it relates to type 1 diabetes
Association services, namely, promoting the public interest and awareness of curing, treating, and preventing type 1 diabetes; promoting public awareness of type 1 diabetes, type 1 diabetes research, and treatments, preventions and cures for type 1 diabetes, by means of public advocacy
